Abstract
Four 99mTc-labeled dibenzylideneacetone derivatives and corresponding rhenium complexes were successfully synthesized and biologically evaluated as potential imaging probes for Aβ plaques using SPECT. All rhenium complexes (5a-d) showed affinity for Aβ(1-42) aggregates (Ki = 13.6-120.9 nM), and selectively stained the Aβ plaques on brain sections of transgenic mice. Biodistribution in normal mice revealed that [99mTc]5a-d exhibited moderate initial uptake (0.31%-0.49% ID/g at 2 min) and reasonable brain washout at 60 min post-injection. Although additional optimizations are still needed to facilitate it's penetration through BBB, the present results indicate that [99mTc]5a may be a potential SPECT probe for imaging Aβ plaques in Alzheimer's brains.
Original language | English (US) |
---|---|
Pages (from-to) | 90-98 |
Number of pages | 9 |
Journal | European Journal of Medicinal Chemistry |
Volume | 64 |
DOIs | |
State | Published - 2013 |
Keywords
- β-Amyloid plaque
- Alzheimer's disease
- Dibenzylideneacetone
- SPECT imaging
- Technetium-99m
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
- Organic Chemistry